Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stenzl

Showing results (91-100 of 925) with videos related to

Pageof 93
Sort By:
Current Opinion in Urology|July 27, 2010
Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?Georgios Gakis, Stephan Kruck, Arnulf Stenzl
Der Urologe. Ausg. A|May 9, 2014
[Transurethral resection of bladder tumors: management of complications]S Rausch, G Gakis, A Stenzl
European Urology Oncology|August 7, 2019
Does it matter whether a T1 high-grade tumor is molecularly classified?Arnulf Stenzl, David McConkey, Joaquim Bellmunt
Zentralblatt Fur Chirurgie|January 1, 1978
[Atypical surgical procedure in massive bleeding from colonic diverticulae]W Stenzl, G Höllerl, F Wiedner
Current Opinion in Urology|July 16, 2013
Optimal use and outcomes of orthotopic neobladder reconstruction in men and womenTilman Todenhöfer, Arnulf Stenzl, Christian Schwentner
European Urology|August 24, 2010
Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8Daniela Colleselli, Arnulf Stenzl, Christian Schwentner
Aktuelle Urologie|March 28, 2018
[Immune checkpoint inhibition in metastatic urothelial carcinoma]Jens Bedke, Tilman Todenhöfer, Arnulf Stenzl
Anticancer Research|July 9, 2011
Disseminated and circulating tumor cells for monitoring chemotherapy in urological tumorsStephan Kruck, Georgios Gakis, Arnulf Stenzl
Der Urologe. Ausg. A|May 18, 2019
[Surgical reconstruction of the ureter]V Stühler, J Bedke, A Stenzl
The World Journal of Men'S Health|July 11, 2020
Role of Multiparametric Magnetic Resonance Imaging in Predicting Pathologic Outcomes in Prostate CancerNiklas Harland, Arnulf Stenzl, Tilman Todenhöfer
Pageof 93

Showing results (91-100 of 925) with videos related to

Sort By:
Pageof 93
Current Opinion in Urology|July 27, 2010
Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?Georgios Gakis, Stephan Kruck, Arnulf Stenzl
Der Urologe. Ausg. A|May 9, 2014
[Transurethral resection of bladder tumors: management of complications]S Rausch, G Gakis, A Stenzl
European Urology Oncology|August 7, 2019
Does it matter whether a T1 high-grade tumor is molecularly classified?Arnulf Stenzl, David McConkey, Joaquim Bellmunt
Zentralblatt Fur Chirurgie|January 1, 1978
[Atypical surgical procedure in massive bleeding from colonic diverticulae]W Stenzl, G Höllerl, F Wiedner
Current Opinion in Urology|July 16, 2013
Optimal use and outcomes of orthotopic neobladder reconstruction in men and womenTilman Todenhöfer, Arnulf Stenzl, Christian Schwentner
European Urology|August 24, 2010
Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8Daniela Colleselli, Arnulf Stenzl, Christian Schwentner
Aktuelle Urologie|March 28, 2018
[Immune checkpoint inhibition in metastatic urothelial carcinoma]Jens Bedke, Tilman Todenhöfer, Arnulf Stenzl
Anticancer Research|July 9, 2011
Disseminated and circulating tumor cells for monitoring chemotherapy in urological tumorsStephan Kruck, Georgios Gakis, Arnulf Stenzl
Der Urologe. Ausg. A|May 18, 2019
[Surgical reconstruction of the ureter]V Stühler, J Bedke, A Stenzl
The World Journal of Men'S Health|July 11, 2020
Role of Multiparametric Magnetic Resonance Imaging in Predicting Pathologic Outcomes in Prostate CancerNiklas Harland, Arnulf Stenzl, Tilman Todenhöfer
Pageof 93